Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sargramostim for Radiation-Induced Mucositis in Laryngeal Cancer
NCT00004256Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Oct 1997
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in mucositis, sponsored by Royal Marsden NHS Foundation Trust. Started Oct 1997; status: completed.
02
Drugs
sargramostim
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT00004256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004256.